Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

De novo drug design through artificial intelligence: an introduction.

Autor: Crucitti, Davide, Pérez Míguez, Carlos, Díaz Arias, José Ángel, Fernandez Prada, Diego Beltrán, Mosquera Orgueira, Adrián

Publikováno v: Frontiers in Hematology; 2024, p1-14, 14p

Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.

Autor: Mosquera Orgueira A; Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain., Perez Encinas MM; Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain., Diaz Varela N; Hospital Central de Asturias, Oviedo, Spain., Wang YH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Mora E; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Diaz-Beya M; Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain., Montoro MJ; Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Pomares Marin H; Hematology, Hospital Duran i Reynals, Institut Català d'Oncologia, Barcelona, Spain., Ramos Ortega F; Hematology, Hospital Universitario de León, León, Spain., Tormo M; Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain., Jerez A; Hematology, Hospital Morales Meseguer, IMIB, Murcia, Spain., Nomdedeu J; Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., de Miguel Sanchez C; Hematology, Hospital Universitario de Álava - Sede Txagorritxu, Vitoria-Gasteiz, Spain., Arenillas L; Laboratoris de Citologia Hematològica i Citogenètica, Servei de Patologia, Hospital del Mar, GRETNHE, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Carcel P; Hematology, Hospital Público Universitario de la Ribera, Valencia, Spain., Cedena Romero MT; Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria i+12, Madrid, Spain., Xicoy Cirici B; HU German Trias i Pujol - Institut Català d' Oncologia, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Rivero Arango E; Hematology, University Hospital Arnau de Vilanova, Lleida, Spain., Del Orbe Barreto RA; Hematology, Hospital Universitario Cruces Servicio de Hematología, Barakaldo, Spain., Benlloch L; Grupo Español de Síndromes Mielodisplásicos, Valencia, Spain., Lin CC; Department of Internal Medicine, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Tien HF; Department of Internal Medicine, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Pérez Míguez C; Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain., Crucitti D; Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain., Díez Campelo M; Hematology, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain., Valcárcel D; Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1529-1535. Date of Electronic Publication: 2024 Feb 27.